EHA Library - The official digital education library of European Hematology Association (EHA)

PLASMAPHERESIS: AN EXPERIENCE IN BLOOD BANK OF A TERTIARY CARE HOSPITAL IN PESHAWAR
Author(s):
Hamzullah Khan
Affiliations:
hematology,Nowshera medical colleg nowshera pakistan,nowshera,Pakistan
(Abstract release date: 05/17/18) EHA Library. Khan H. 06/14/18; 216803; PB2544
Hamzullah Khan
Hamzullah Khan
Contributions
Abstract

Abstract: PB2544

Type: Publication Only

Background
plasmapheresis for therapeutic purposes is less practiced in Pakistan. It has a therapeutic as well as diagnostic importance and present study is a continuation of the above statement

Aims
To determine the frequency of major indications require plasmapheresis in blood bank of Lady Reading Hospital Peshawar. 

Methods
This cross sectional study was conducted in blood bank of Lady Reading Hospital Peshawar from june 2010 to June 2012. Relevant information’s were recorded on a pre-designed questionnaire prepared in accordance with the objectives of the study

Results
A total of 54 patients were enrolled in the trial. 23 (42.59%) were females, and 31(57.41%) were males. Males to females ration was 1.4:1. We received patients for plasmaphersis in age ranging from 15 to 74 years. Majority were young patients in age range 15 to 34 years age. We received majority of the patients for the subject procedure from ICU(Intensive care unit) 20(73%), followed by cardiothoracic unit 17(31.48%). We also receive two volunteers during study. The frequency of various indications for plasmapheresis were; myasthenia gravis 29(53.7%), Guillen barre syndrome 20(37.04%) and thrombocytopenic purpura 3(5.56%). 

Conclusion
From this study we concluded that the autoimmune diseases are common in younger age which is a very serious concern for our society. Plasmapheresis is a therapeutic procedure as well and patients with autoimmune disorders get relieved with it symptomatically as autoimmune antibodies are removed. Myasthenia gravis was counted as major disease followed by GBS and thrombocytopenic purpura in our population. 

Session topic: 32. Transfusion medicine

Keyword(s): Plasma

Abstract: PB2544

Type: Publication Only

Background
plasmapheresis for therapeutic purposes is less practiced in Pakistan. It has a therapeutic as well as diagnostic importance and present study is a continuation of the above statement

Aims
To determine the frequency of major indications require plasmapheresis in blood bank of Lady Reading Hospital Peshawar. 

Methods
This cross sectional study was conducted in blood bank of Lady Reading Hospital Peshawar from june 2010 to June 2012. Relevant information’s were recorded on a pre-designed questionnaire prepared in accordance with the objectives of the study

Results
A total of 54 patients were enrolled in the trial. 23 (42.59%) were females, and 31(57.41%) were males. Males to females ration was 1.4:1. We received patients for plasmaphersis in age ranging from 15 to 74 years. Majority were young patients in age range 15 to 34 years age. We received majority of the patients for the subject procedure from ICU(Intensive care unit) 20(73%), followed by cardiothoracic unit 17(31.48%). We also receive two volunteers during study. The frequency of various indications for plasmapheresis were; myasthenia gravis 29(53.7%), Guillen barre syndrome 20(37.04%) and thrombocytopenic purpura 3(5.56%). 

Conclusion
From this study we concluded that the autoimmune diseases are common in younger age which is a very serious concern for our society. Plasmapheresis is a therapeutic procedure as well and patients with autoimmune disorders get relieved with it symptomatically as autoimmune antibodies are removed. Myasthenia gravis was counted as major disease followed by GBS and thrombocytopenic purpura in our population. 

Session topic: 32. Transfusion medicine

Keyword(s): Plasma

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies